Log in to save to my catalogue

Expression of LMO2 in Prostate Carcinoma and Adjacent Prostatic Parenchyma

Expression of LMO2 in Prostate Carcinoma and Adjacent Prostatic Parenchyma

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_11c502ba5005457e87003f94175491d6

Expression of LMO2 in Prostate Carcinoma and Adjacent Prostatic Parenchyma

About this item

Full title

Expression of LMO2 in Prostate Carcinoma and Adjacent Prostatic Parenchyma

Publisher

Croatia: Sestre Milosrdnice University hospital, Institute of Clinical Medical Research

Journal title

Acta clinica Croatica (Tisak), 2018-10, Vol.57 (Suppl 1), p.56-60

Language

English

Formats

Publication information

Publisher

Croatia: Sestre Milosrdnice University hospital, Institute of Clinical Medical Research

More information

Scope and Contents

Contents

LMO2 (LIM domain only) is a member of transcription factor family of proteins characterized by their cysteine-rich, zinc-binding LIM domains. Its expression in prostate cancer cells, as well as in adjacent stroma, is described in a study in a cohort of 83 patients treated with radical prostatectomy for clinically localized prostate adenocarcinoma....

Alternative Titles

Full title

Expression of LMO2 in Prostate Carcinoma and Adjacent Prostatic Parenchyma

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_doaj_primary_oai_doaj_org_article_11c502ba5005457e87003f94175491d6

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_11c502ba5005457e87003f94175491d6

Other Identifiers

ISSN

0353-9466

E-ISSN

1333-9451

DOI

10.20471/acc.2018.57.s1.08

How to access this item